Ion Channel Genetic Biomarkers: Diagnostic Capabilities in the Assessment of Bipolar Disorder

Completed

Conditions studied: Bipolar Disorder

In brief

Genotype 164 adults to evaluate six selected single nucleotide polymorphisms (SNPs) (rs1006737, rs10994336, rs10994133, rs2238071, rs1051375, rs1024582) for use as a genetic biomarker to differentiate between bipolar depression and unipolar depression.

Key facts

Study ID

NCT03572426

Run by

University of Colorado, Denver

People needed

164

Starts

2018-06-13

Expected to finish

2019-04-04

Last updated by the study team

2019-07-10

Who can join

Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• presenting to one of 4 Denver Metro Area clinics
• Subjects must fall into one of 3 diagnostic categories, bipolar, MDD, or no mood symptoms.

You may not qualify if…

• Inability to provide informed consent
• history of TBI
• history of untreated seizure disorder
• substance abuse in the last 8 hours
• moderate-severe substance abuse disorder diagnosed in the last 6 months

Where it is running

• Helen and Arthur E Johnson Depression Center — Aurora, Colorado, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.